loadpatents
name:-0.045780897140503
name:-0.012948989868164
name:-0.0081188678741455
Sherman; Matthew L. Patent Filings

Sherman; Matthew L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sherman; Matthew L..The latest application filed is for "antagonists of activin-actriia and uses for increasing red blood cell levels".

Company Profile
8.14.40
  • Sherman; Matthew L. - Cambridge MA
  • Sherman; Matthew L. - Newton MA
  • - Newton MA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antagonists Of Activin-actriia And Uses For Increasing Red Blood Cell Levels
App 20220204576 - Sherman; Matthew L. ;   et al.
2022-06-30
Activin-actrii Antagonists And Uses For Increasing Red Blood Cell Levels
App 20220204588 - Sherman; Matthew L.
2022-06-30
Methods For Dosing An Actriib Antagonist And Monitoring Of Treated Patients
App 20220118049 - Sherman; Matthew L. ;   et al.
2022-04-21
Activin-actrii Antagonists And Uses For Increasing Red Blood Cell Levels
App 20210355191 - Sherman; Matthew L.
2021-11-18
Antagonists Of Activin-actriia And Uses For Increasing Red Blood Cell Levels
App 20210355181 - Sherman; Matthew L. ;   et al.
2021-11-18
Methods For Treating Fatty Liver Disease
App 20210269494 - Koncarevic; Alan ;   et al.
2021-09-02
Methods For Dosing An Actriib Antagonist And Monitoring Of Treated Patients
App 20200360475 - Sherman; Matthew L. ;   et al.
2020-11-19
Antagonists Of Actriib And Uses For Increasing Red Blood Cell Levels
App 20200255495 - Kind Code
2020-08-13
Methods For Treating Eye Disorders
App 20200071383 - Sherman; Matthew L. ;   et al.
2020-03-05
Methods for treating vascular eye disorders with actrii antagonists
Grant 10,550,170 - Sherman , et al. Fe
2020-02-04
Activin-actrii Antagonists And Uses For Increasing Red Blood Cell Levels
App 20200031903 - Sherman; Matthew L.
2020-01-30
Antagonists Of Activin-actriia And Uses For Increasing Red Blood Cell Levels
App 20190225664 - Sherman; Matthew L. ;   et al.
2019-07-25
Methods for treating vascular eye disorders with actrii antagonists
Grant 10301372 -
2019-05-28
Methods For Treating Fatty Liver Disease
App 20190062392 - Koncarevic; Alan ;   et al.
2019-02-28
Antagonists of activin-ActRIIa and uses for increasing red blood cell levels
Grant 10,093,707 - Sherman , et al. October 9, 2
2018-10-09
Follistatin fusion proteins and uses thereof
Grant 9,919,030 - Sherman March 20, 2
2018-03-20
Antagonists Of Actriib And Uses For Increasing Red Blood Cell Levels
App 20180009872 - Sherman; Matthew L. ;   et al.
2018-01-11
Methods For Treating Eye Disorders
App 20170291935 - Sherman; Matthew L. ;   et al.
2017-10-12
Activin-actriia Antagonists For Inhibiting Germ Cell Maturation
App 20160319254 - Knopf; John ;   et al.
2016-11-03
Methods For Treating Fatty Liver Disease
App 20160318983 - Koncarevic; Alan ;   et al.
2016-11-03
Methods For Dosing An Activin-actriia Antagonist And Monitoring Of Treated Patients
App 20160279203 - Sherman; Matthew L. ;   et al.
2016-09-29
Methods For Dosing An Actriib Antagonist And Monitoring Of Treated Patients
App 20160279197 - Sherman; Matthew L. ;   et al.
2016-09-29
Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumor
Grant 9,353,356 - Knopf , et al. May 31, 2
2016-05-31
Antagonists Of Activin-actriia And Uses For Increasing Red Blood Cell Levels
App 20150183845 - Sherman; Matthew L. ;   et al.
2015-07-02
Follistatin Fusion Proteins and Uses Thereof
App 20150158923 - Sherman; Matthew L. ;   et al.
2015-06-11
Antagonists of activin-actriia and uses for increasing red blood cell levels
Grant 8,895,016 - Sherman , et al. November 25, 2
2014-11-25
Treatment Of Cancer With Alk1 Antagonists
App 20140193425 - Knopf; John ;   et al.
2014-07-10
Activin-actriia Antagonists For Inhibiting Germ Cell Maturation
App 20130195862 - Knopf; John ;   et al.
2013-08-01
Activin-actriia antagonists for inhibiting germ cell maturation
Grant 8,367,611 - Knopf , et al. February 5, 2
2013-02-05
Activin-actrii Antagonists And Uses For Increasing Red Blood Cell Levels
App 20120052067 - Sherman; Matthew L.
2012-03-01
Antagonists Of Actriib And Uses For Increasing Red Blood Cell Levels
App 20120003218 - Sherman; Matthew L. ;   et al.
2012-01-05
Activin-actriia Antagonists For Inhibiting Germ Cell Maturation
App 20110218147 - Knopf; John ;   et al.
2011-09-08
Activin-actrii antagonists and uses for increasing red blood cell levels
Grant 8,007,809 - Sherman August 30, 2
2011-08-30
Activin-ActRII antagonists and uses for increasing red blood cell levels
Grant 7,988,973 - Sherman August 2, 2
2011-08-02
Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion
Grant 7,960,343 - Knopf , et al. June 14, 2
2011-06-14
Methods For Treating Fatty Liver Disease
App 20110129469 - Koncarevic; Alan ;   et al.
2011-06-02
Activin-actrii antagonists and uses for increasing red blood cell levels
App 20100204092 - Sherman; Matthew L.
2010-08-12
Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome
Grant 7,727,968 - Feingold , et al. June 1, 2
2010-06-01
Antagonists of activin-actriia and uses for increasing red blood cell levels
App 20100028331 - Sherman; Matthew L. ;   et al.
2010-02-04
Antagonists of actriib and uses for increasing red blood cell levels
App 20100028332 - Sherman; Matthew L. ;   et al.
2010-02-04
Methods for dosing an activin-actriia antagonist and monitoring of treated patients
App 20100015144 - Sherman; Matthew L. ;   et al.
2010-01-21
Methods for dosing an actriib antagonist and monitoring of treated patients
App 20100008918 - Sherman; Matthew L. ;   et al.
2010-01-14
Activin-actrii antagonists and uses for increasing red blood cell levels
App 20090163417 - Sherman; Matthew L.
2009-06-25
Activin-actriia antagonists and uses for decreasing or inhibiting FSH secretion
App 20090118188 - Knopf; John ;   et al.
2009-05-07
Activin-ActRII antagonists and uses for increasing red blood cell levels
App 20090047281 - Sherman; Matthew L.
2009-02-19
Bis(thio-hydrazide amides) for treatment of hyperplasia
App 20060142393 - Sherman; Matthew L. ;   et al.
2006-06-29
Antineoplastic combinations of CCI-779 and rituximab
App 20050272758 - Bayever, Eliel ;   et al.
2005-12-08
Treatment of aromatase inhibitor therapy-related osteoporosis
App 20050272717 - Jenkins, Simon N. ;   et al.
2005-12-08
Antineoplastic agents
App 20040258662 - Gibbons, James J. JR. ;   et al.
2004-12-23
Antineoplastic combinations
App 20040176339 - Sherman, Matthew L. ;   et al.
2004-09-09
Treatment of Kaposi's sarcoma with IL-12
App 20030190305 - Yarchoan, Robert ;   et al.
2003-10-09
Treatment of Kaposi's sarcoma with IL-12
Grant 6,509,321 - Yarchoan , et al. January 21, 2
2003-01-21
Treatment of Kaposi's sarcoma with IL-12
Grant 6,423,308 - Yarchoan , et al. July 23, 2
2002-07-23
Company Registrations
SEC0001325710Sherman Matthew L

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed